131I-MIBG

metaiodobenzylguanidine

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for 131I-MIBG, covering 2012-06-04 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol